Wednesday, October 31, 2012

Nuclear Medicine: PET Radiopharmaceutical Receives European Endorsement for Imaging of β-Amyloid Density

A European health agency has recommended marketing authorization for Amyvid (florbetapir 18F) as a diagnostic imaging agent in patients who are being evaluated for Alzheimer’s disease (AD) and other causes of cognitive decline.

Monday, October 29, 2012

Radiography: 3D CT Breast Cancer Scanning Technology

Newly developed technology provides three-dimensional (3D) X-ray imaging of the breast with a radiation dose that is lower than the current 2D X-ray imaging used in clinics.

Sunday, October 28, 2012

MRI: MRI Proves Effective Guiding Heart Catheter Procedures

Heart catheter procedures guided by magnetic resonance imaging (MRI) are as safe as X-ray-guided procedures and do not take any longer, according to a pilot study.

Thursday, October 25, 2012

Men's Health: Task Force Recommends Against Hormone Replacement Therapy for Postmenopausal Women

The United States Preventive Services Task Force recommends against the use of estrogen and progestin for the prevention of chronic medical conditions in postmenopausal women

Wednesday, October 24, 2012

Imaging IT: New DICOM Guard Technology for high patient Data safety

A new Digital Imaging and Communications in Medicine (DICOM) application features proprietary data tagging technology, which allows healthcare enterprises to have complete control over security of their patient data.

Monday, October 22, 2012

Ultrasound: Collaborative Efforts to Develop Medical Ultrasound Practice Guidelines

American medical societies have collaborated on a guideline that comprises indications for an ultrasound examination for a focused reproductive endocrinology and infertility scan.

Sunday, October 21, 2012

Nuclear Medicine: The specificity and overall accuracy of F-18-FLT were considerably higher than F-18-FDG PET both during and after radiation therapy.

Determining the optimal treatment course and predicting outcomes may soon become simpler for head and neck sqaumous cell carcinomas (HNSCCs) patients with the use of a new investigational imaging agent.

Friday, October 19, 2012

Psoriasis: Investigation found a clear association between psoriasis and diabetes

An analysis of 27 studies linking psoriasis in 314,000 individuals with diabetes has found strong correlation between the scaly skin rash and the blood sugar disorder that predisposes patients to heart disease, say UC Davis researchers who led the review.

Wednesday, October 17, 2012

Nuclear Medicine: New Radiation Treatment Significantly Increases Survival Rate

A novel drug that mimics a naturally occurring molecule found in coffee and blueberries has been developed to treat radiation exposure. Charles R. Yates, Pharm.D., Ph.D., and colleagues Duane Miller, Ph.D., and Waleed Gaber, Ph.D.,

Monday, October 15, 2012

Cosmetic Medicine: Sea cucumbers and sea urchins are able to change the elasticity of collagen within their bodies

Sea cucumbers and sea urchins are able to change the elasticity of collagen within their bodies, and could hold the key to maintaining a youthful appearance, according to scientists at Queen Mary, University of London.

Sunday, October 14, 2012

Drinking alcohol and smoking have to throw together

New research verifies previous studies by Dr. Timothy Durazzo and his colleagues, showing that smoking, while trying to quit drinking alcohol, impairs learning, memory, and other cognitive skills, hindering successful sobriety.

Wednesday, October 10, 2012

Value-based pricing is one potential solution to reduce the cost of drugs

A virtual monopoly held by some drug manufacturers in part because of the way treatment protocols work is among the reasons cancer drugs cost so much in the United States, according to a commentary by two Mayo Clinic physicians in the October issue of the journal Mayo Clinic Proceedings. Value-based pricing is one potential solution, they write.

Tuesday, October 9, 2012

Subcutaneous Formulation Of ORENCIA® (Abatacept) Approved By European Commission

Bristol-Myers Squibb have announced that the European Commission has granted marketing authorisation for the subcutaneous formulation of ORENCIA® (abatacept), in combination with methotrexate (MTX), for the treatment of adults with moderate to severe active rheumatoid arthritis (RA).

Sunday, October 7, 2012

Cardiology: Heart Attack Mortality Risk Greater For People With Schizophrenia

The risk of death resulting from heart attack is higher in people with schizophrenia than in the general public, according to scientists at the Centre for Addiction and Mental Health (CAMH) and the Institute for Clinical Evaluative Sciences (ICES).

Saturday, October 6, 2012

MRI: Supposed Benign Condition Shown to Alter Brain Function in the Elderly

Researchers are reporting that a common condition called leukoaraiosis, comprised of tiny areas in the brain that have been deprived of oxygen and appear as bright white dots on magnetic resonance imaging (MRI) scans, is not a harmless part of the aging process, but instead a disease that changes brain function in the elderly.

Thursday, October 4, 2012

New Maryland Law Enables Consumers To Select Qualified Physicians

A new Maryland law effective today requires physicians who publicize board certification to announce their certifying board as well as their speciality.

Wednesday, October 3, 2012

Imaging IT: Healthcare Organizations Utilize Enterprise Services to Fast-Track Health IT Purchases

New enterprise services help healthcare providers predict operational and information technology (IT) costs and control ongoing costs while deploying enterprise-wide health IT systems.

Tuesday, October 2, 2012

Ultrasound: Partnership to Offer Advanced Needle Guidance technology

New needle guidance solution helps make central venous catheter procedures “point-and-shoot” simple to improve care quality and reduce healthcare costs.